Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The Numbers...
The $16 mil is half (PTSC's take) of what Pohl stated as what PDS took in as revs from June 1 - Oct 3.. this is Q1 of this year. The other $35 mil is for fiscal yr ending May 31
Share
New Message
Please login to post a reply